Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene.
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 43 (2) , 279-289
- https://doi.org/10.1023/a:1018889818855
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Inhibition of Cell Growth by Transforming Growth Factor β1 Is Associated with p53‐Independent Induction of p21 in Gastric Carcinoma CellsJapanese Journal of Cancer Research, 1996
- The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinomaBritish Journal of Cancer, 1994
- Sequence-specific interaction of a conformational domain of p53 with DNA.1993
- p53 Mutation in gastric cancer: A genetic model for carcinogenesis is common to gastric and colorectal cancerInternational Journal of Cancer, 1993
- Prognostic significance of human papillomavirus genomes (type‐16, ‐18) and aberrant expression of p53 protein in human esophageal cancerInternational Journal of Cancer, 1993
- Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodesBritish Journal of Cancer, 1993
- Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coliJournal of Cell Science, 1992
- Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer.1991
- Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.Proceedings of the National Academy of Sciences, 1990
- CLONING AND CHARACTERIZATION OF A CDNA FROM XENOPUS-LAEVIS CODING FOR A PROTEIN HOMOLOGOUS TO HUMAN AND MURINE P531987